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Abstract
Background: To evaluate the effects on serum 25(OH)D and bone mineralization of supplementation of breast-fed
Hispanic and non-Hispanic Caucasian infants with vitamin D in infants in Houston, Texas.
Methods: We measured cord serum 25(OH)D levels, bone mineral content (BMC), bone mineral density (BMD) and
their changes over 3 months of life with 400 IU/day of vitamin D3 supplementation.
Results: Cord serum 25(OH)D was significantly lower in Hispanic than non-Hispanic Caucasian infants (16.4 ± 6.5
ng/mL, n = 27, vs 22.3 ± 9.4 n = 22, p = 0.013). Among 38 infants who completed a 3 month vitamin D
supplementation intervention, provision of 400 IU/day of vitamin D increased final 25(OH)D to a higher level in
non-Hispanic Caucasian compared to Hispanic infants. There was no significant relationship between cord serum
25(OH)D and BMC or BMD in the first week of life (n = 49) or after 3 months of vitamin D supplementation.
Conclusion: Low cord 25(OH)D levels are seen in Hispanic infants, but their functional significance is uncertain
related to bone health in a southern US setting. Daily vitamin D intake of 400 IU during the first months of life
appears adequate to increase serum 25(OH)D and support BMC increases despite low initial 25(OH)D levels in
some infants.Trial Registration
ClincalTrials.gov NCT00697294
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Background
Vitamin D has been given to infants to prevent and treat
rickets for almost 100 years. The recommended dose of
400 IU (10 micrograms) daily for infants was established
based on typical amounts in a teaspoon of cod liver oil [1].
This recommendation has recently been reaffirmed as
being appropriate by both the Institute of Medicine [2]
and the American Academy of Pediatrics [3] whereas the
Endocrine Society considers the 400 IU to be a minimum
appropriate dose [4]. Although the dose of 400 IU daily is
used for both breast-fed and formula-fed babies, vitamin
D-deficient rickets is extremely rare in formula-fed infants
primarily due to the mandatory addition of vitamin D to
infant formulas in the United States. Formula-fed infants
typically consume 300-500 IU/day from their formula and
therefore generally meet the current recommendations
without an additional oral supplement of vitamin D drops
especially after the first 6 to 8 weeks of life. The relatively
greater calcium and phosphorus concentration in US
infant formulas compared to human milk may also be pro-
tective against rickets in some infants.
Remarkably, few data have looked at modern techniques
of assessing bone mineral status and compared it to vita-
min D levels and supplementation in this population [5].
Serum 25-hydroxyvitamin D (25(OH)D) is accepted as the
best marker of vitamin D status although it may serve pri-
marily as a marker of exposure rather than clinical out-
comes [2].There are few data that correlate serum 25(OH)
D levels with functional outcomes in newborns and small
infants.
Neonatal serum 25(OH)D levels reflect a range of
in utero factors, most significant of these being the
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phosphorus are transported transplacentally without
vitamin D, the effects of low vitamin D in utero or
shortly after birth are uncertain [7].
This study was conducted to evaluate early life bone
mineral content (BMC) and the effects of three months
of vitamin D supplementation in breast-fed Hispanic and
non-Hispanic Caucasian (henceforth, “Caucasian”)
infants on vitamin D levels. We hypothesized that 25
(OH)D would be lower in Hispanic than Caucasian new-
borns but that these differences would not be substantial
enough to be related closely to BMC and bone mineral
density (BMD) or their changes during the first three
months of life.
Due to the guidelines for providing vitamin D supple-
ments to all breast-fed infants, it is not ethically possible
to conduct a placebo-controlled study of vitamin D sup-
plementation in the United States. However, the relation-
ship between vitamin D status and bone-related outcomes
in supplemented infants provides information about the
effects of these cord levels and vitamin D supplementation
in early infancy. Furthermore, few data have evaluated His-
panic infants who may be at high-risk for low vitamin D
status due to poor maternal vitamin D intake [4].
Methods
Subjects
Subjects were recruited from two hospitals in the Texas
Medical Center in Houston, Texas. The latitude of Hous-
ton, TX is 29 degrees, more southern than the typically
used latitude cutoff of Atlanta, Georgia of 33 degrees for
sunlight exposure to lead to vitamin D formation in the
dermis to occur throughout the year. The two hospitals
consisted of a private hospital from which most of the
Caucasian subjects were recruited (St. Luke’sE p i s c o p a l
Hospital) and a nearby public hospital (Ben Taub General
Hospital) from which nearly all of the Hispanic patients
were recruited. Subjects were enrolled whose mother was
healthy (non insulin-dependent diabetic, no other major
pregnancy complications), who were expected to have a
singleton, non-small for dates infant, and had been
admitted to the labor and delivery unit due to the onset of
labor or were admitted for a planned induction or c-sec-
tion delivery at 37 to 41 weeks gestation. Consent was
obtained prior to delivery. Approval was obtained from
the Institutional Review Board of Baylor College of Medi-
cine and Affiliated Hospitals.
Procedures
Cord blood was obtained at birth for analysis of 25(OH)D
and ionized calcium. One week later, subjects returned to
the research facility for whole body dual-energy x-ray
absorptiometry (DXA) measurements and to receive the
vitamin D supplements (400 IU/mL) with instructions to
give daily by mouth until the final study visit. Subjects
who attended this visit were considered enrolled.
Mothers were instructed to continue the supplements as
long as they were breastfeeding. If a mother weaned her
child to an exclusively formula-fed diet, she was
instructed to discontinue the supplements but to return
for the final study visit regardless. A brief questionnaire
on prenatal vitamins, including name and frequency, and
intake of vitamin D rich foods was completed. The Mus-
lim community in Houston represents about 3% of the
population, and therefore, mothers were asked if they
had any religious or cultural practices that included cov-
ering their head and bodies with clothing in the context
that this may affect sunlight exposure and therefore cord
25(OHD) values. Other lifestyle and dress habits were
not evaluated, and all participants were observed by the
study staff for typical Western-style US clothing (sleeve-
less or short-sleeved shirts in the summer, jackets or
coats in the winter).
The final study visit was conducted at three months of
age. Subjects returned for a repeat DXA scan and a serum
sample was obtained for 25(OH)D and parathyroid hor-
mone (PTH) levels. Mothers were asked to return the sup-
plements bottles at the final visit. The weight of the
supplements bottles at this visit compared to when they
were given to the mothers at the first visit was used as a
measure of compliance of how often the drops were given
to the infant. Birth weight and gestational age were
recorded for each infant. Anthropometrics were recorded
at each outpatient visit using a digital scale and length
board. Cord blood and infant blood at three months of
age were analyzed for 25(OH)D concentration by DiaSorin
radioimmunoassay (DiaSorin Inc., Stillwater MN) at Yale
University. Results of samples analyzed in this assay are
consistently found to agree with the mid-range of out-
comes of those using this assay and participating in the
international DEQUAS standardization system. The inter-
and intra-assay coefficients of variation in that laboratory
are 9.6% and 6.6%, respectively. Ionized calcium was mea-
sured from cord blood using standard clinical measure-
ment techniques in the blood gas laboratories of the
respective hospitals. Intact PTH was measured by immu-
nochemiluminometric assay (ICNA) with a sensitivity of 3
pg/mL. Throughout the manuscript, we have provided
values for 25(OH)D as ng/mL, these may be multiplied by
2.5 to obtain results in nmol/L.
Whole body DXA measurements, BMC, and BMD were
conducted using Hologic Delphi Model (Hologic Inc.,
Waltham MA). Reproducibility of DXA Infant Scans;
BMC = 3.8% and BMD = 4.1%. The DXA instrument
undergoes regularly scheduled quality control testing for
phantom reproducibility and signal uniformity. Subject
scanning does not take place unless all quality control
results fall within acceptable limits. Serum 25-OHD was
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Sorin, Stillwater, MN).
Statistical Analysis
Sample size determination (at least 16 each Hispanic and
Caucasian) was done to identify a one standard deviation
difference in the change in bone mineralization between
one week of age and three months of age by ethnicity. Dif-
ferences markedly less than are less likely to be biologically
relevant and this study was not designed to identify small
differences.
Comparisons of values between study time points were
made using a generalized linear regression model with
covariate adjustment based on the specific analysis con-
ducted. Analysis was performed using SPSS 18.0 for
Macintosh (SPSS, Inc., Chicago, IL). Simple and multiple
regression analysis were used as appropriate. Significance
was assumed at a p < 0.05. All data are presented as the
mean ± SD except as noted. Statistical analysis was not
applied to the relative change in serum 25(OH)D values
with low baseline versus high baseline data as there is cur-
rently no accepted optimal approach for such an evalua-
tion as reviewed recently by Tu and Gilthorpe [8]. To
convert serum vitamin D levels from ng/mL to nmol/L,
multiply by 2.5.
Results
Cord blood and initial bone mineralization values
A total of 49 singleton infants were enrolled at one week
of age for this research project. Of these, 38 (78%)
returned at three months for the final study visit. There
was no significant effect of birth hospital on the serum 25
(OH)D level when ethnicity was accounted for by covari-
ate analysis (p = 0.37).
Of the 49 study subjects, 22 were Caucasian and 27 His-
panic. The mean serum cord 25(OH)D values for each
group were 22.3 ± 9.4 ng/mL for Caucasian and 16.4 ± 6.5
ng/mL for Hispanic infants (p = 0.013 for difference). We
evaluated the relationship between cord blood 25(OH)D
a n dB M Ca n dB M Da to n ew e e ko fa g e .C o r d2 5 ( O H ) D
was not significantly related to BMC (p = 0.39) or BMD
(also, p = 0.39). BMC was highly correlated to body weight
(r = 0.86, p < 0.001) as was BMD (r = 0.56, p < 0.001).
BMC was significantly related to length at one week (r =
0.61, p < 0.001) however, in multivariate analysis including
weight and length, only weight was significant, p < 0.001
and length was not significant, p = 0.87. Length was simi-
lar between Hispanic and Caucasians, 50.3 ± 2.1 cm versus
50.5 ± 2.0 cm respectively, p = 0.72. Weight was also not
significantly different between groups at this time, 3.68 ±
0.4 kg versus 3.47 ± 0.4 kg for Hispanic and Caucasians
respectively, p = 0.08.
Cord 25(OH)D averaged 14.9 ng/mL and BMC at one
week of life averaged 70.3 g for the 2 Caucasian infants
who did not return at 3 months. Cord 25(OH)D aver-
aged 16.3 ng/mL and BMC at one week of life averaged
72.6 g for the 8 Hispanic infants who did not return at
3 months.
Two mothers (1 Hispanic, 1 Caucasian) reported cover-
ing their face and body due to their religious beliefs. No
other clothing or lifestyle habits affecting sunlight expo-
sure were observed by the study staff as related to ethni-
city. All mothers reported taking a prenatal vitamin
supplement throughout the pregnancy. None of the
mothers reported taking additional vitamin D supplements
separate from their prenatal vitamins. Prenatal vitamin
supplement composition varied by brand; however, most
brands included 200 IU vitamin D per pill. Average mater-
nal intake of vitamin D from foods and prenatal supple-
ments was 439 ± 94 IU/day.
Results at 3 months
Overall compliance with the vitamin D drops was excel-
lent with 90% of the drops given overall based on mea-
surement of the volume of returned droppers. There was
no relationship between compliance and outcome so this
was not further considered in the analysis. Overall, 47% of
the infants (18/39) were exclusively breast-fed at 3
months, 28% primarily breast-fed (51-90% human milk)
and 25% primarily formula-fed. Results were not related to
feeding type.
Results for the 38 infants (19 Hispanic and 19 Cauca-
sian), with the values obtained initially, are shown in Table
1. Of note is that the BMC and BMD were greater in His-
panic infants at three months but not at one week of age.
When looking at the change in BMC during the study per-
iod, the change was significantly greater in Hispanic
infants than Caucasians (51.0 ± 11.3 g vs 41.2 ± 10.1 g, p =
0.006). For BMD, changes were greater in Hispanic than
Caucasians (0.019 ± 0.012 g/cm
2 vs 0.010 ± 0.012 g/cm
2,
p = 0.017). When body weight at three months was
included as a covariate in this analysis, changes in BMC
remained significant, p = 0.03, but changes in BMD were
not (p = 0.06). Overall, there was no relationship between
changes in 25(OH)D and BMC (Figure 1).
We further evaluated the relationship between cord 25
(OH)D and outcomes using a general linear regression
model. For this model, gender, birth weight, season of
measurement and ethnicity were covariates. There was
no significant effect of the percent of human milk pro-
vided on outcomes including change in BMC (p = 0.89)
or change in 25(OH)D (p = 0.25) so all data were ana-
lyzed without amount of human milk included as a cov-
ariate. We found that cord 25(OH)D (dependent
variable) was not significantly related to BMC and BMD
as shown before, and was not closely related to BMC at
three months (p = 0.10). Cord and 3-month 25(OH)D
levels were not significantly related to weight, length or
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Non-Hispanic Caucasian (n = 19) Hispanic (n = 19) p-value
Cord 25(OH)D (ng/mL) 23.0 ± 9.4 16.9 ± 7.2 0.03
BMC at one week (g) 69.4 ± 9.1 72.8 ± 9.2 0.27
BMD at one week (g/cm2) 0.196 ± 0.010 0.199 ± 0.011 0.29
3 month BMC (g) 110.6 ± 13.9 123.8 ± 13.4 0.005
3 month PTH (ng/L) 14.4 ± 16.4 (n = 19) 17.6 ± 10.5 (n = 18) 0.48
3 month total serum Ca (mg/dL) 10.6 ± 0.4 (n = 19) 10.6 ± 0.4 (n = 17) 0.70
3 month BMD (g/cm2) 0.205 ± 0.013 0.219 ± 0.012 0.002
3 month weight (kg) 6.0 ± 5.8 6.4 ± 6.1 0.10
3 month length (cm) 60.6 ± 2.2 61.2 ± 2.7 0.41
3 month 25(OH)D (ng/mL) 37.7 ± 7.6 31.2 ± 8.1 0.014
Data are Mean ± SD.
BMC = bone mineral content
BMD = bone mineral density
PTH = serum parathyroid hormone
25(OH)D = serum 25-hydroxyvitamin D concentration (conversion to nmol/L is by multiplying values shown by 2.5)
For entire 49 subjects enrolled: Values for cord 25(OH)D, Non-Hispanic Caucasian (n = 22), 22.3 ± 9.4 ng/mL and Hispanic (n = 27), 16.4 ± 6.5 ng/mL, p = 0.01.
Values for BMC at one week, Non-Hispanic Caucasians, (n = 22), 69.5+8.8 (g) and Hispanic, (n = 27), 72.4 ± 9.2 (g), p = 0.27. Note that values in ng/mL can be
converted to nmol/L by multiplying by 2.5.
Figure 1 Relationship between changes in 25(OH)D level during 3 months of supplementation and change in total body bone mineral
content, r = 0.17, p = 0.30, effect size = 0.18. Note that values in ng/mL can be converted to nmol/L by multiplying by 2.5.
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25(OH)D levels were not closely related to BMC at 3
months, r = 0.22, p = 0.18.
We considered infants with cord 25(OH)D below 20
ng/mL compared to those above 20 ng/mL regardless of
ethnicity. As shown in Figure 2, there was a greater
increase in 25(OH)D in those with starting values < 20
ng/mL (n = 18, increase of 20.4 ± 8.2 ng/mL) versus an
increase of 9.2 ± 10.6 ng/mL in those 20 subjects with a
starting 25(OH)D value > 20 ng/mL (Figure 2).
Discussion
We found 25(OH)D levels < 20 ng/mL to be common in
the cord blood of infants in a southern climate in the
United States representing about 60% of the infants in
our study, with about 20% of the infants having values ≤
10 ng/mL. However, we did not identify any specific phy-
siological consequences of these cord 25(OH)D levels for
bone mineralization at birth as evidenced by initial DXA
measurements. Supplementation with 400 IU/day of vita-
min D to these infants led to a relatively greater increase
in those who were born with the lowest vitamin D status
and there was no suggestion of any bone mineral out-
come deficits at one week or three months of age in
infants with low cord 25(OH)D levels. We also did not
find any significant relationship between cord 25(OH)D
values and growth outcomes. We note that our study was
of limited size however, and that larger studies are
needed in diverse global populations. Our study did not
have the ability to identify the effects of small amounts of
formula or other nutritional differences between groups.
The close relationships between weight and length and
initial BMC imply that calcium transfer across the pla-
centa is closely related to overall nutrient transfer and
not to vitamin D status (7). Of note is that few subjects
had a cord 25(OH)D < 6 ng/mL, a value found in studies
in pregnant women and newborns in the Middle East
[9,10]. Neonatal rickets and hypocalcemia have been
reported in some, but not all infants with cord or mater-
nal 25(OH)D values < 6-10 ng/mL from the Middle East.
These extremely low values are not commonly reported
in the United States, although we speculate that an
increasing number of cases may be reported in the future
due to increased awareness of vitamin D deficiency.
Figure 2 Baseline and final values for 25(OH)D in 38 subjects based on initial values above or below 20 ng/mL. Note that values in ng/
mL can be converted to nmol/L by multiplying by 2.5.
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the Hispanic population and no data looking specifically
at the relative increase over time based on cord 25(OH)
D[ 1 1 ] .W ed i dn o th a v eP T Hv a l u e so nt h ec o r db l o o d
but PTH values at three months of age were not corre-
lated significantly with 25(OH)D values at birth or three
months or with bone mineral outcomes. Differences in
25(OH)D between Hispanic and Caucasian infants may
be related to lifestyle including sunshine exposure.
These were not evaluated in this study but there are no
clear cultural reasons to expect a substantial difference
in Houston.
In a European population, 64% of infants had a serum
25(OH)D at 3-6 days of age that was below 12 ng/mL
[12]. Of note is that in that study, about 10% of infants
with these very low 25(OH)D levels had evidence of hypo-
calcemia although none had physical symptoms and it is
not clear if there was a true cause and effect in this group.
Although there was a trend in that study towards a relative
increase in 25(OH)D in infants with lower baseline values
who received supplementation, this was not clearly
demonstrated. In the United States, median values for 25
(OH)D in a northern setting in the first days of life were
17 ng/mL with 58% of infants < 20 ng/mL, results very
similar to those seen in our study [13].
We found similar ionized calcium levels in Hispanic
and Caucasians at birth. There is some suggestion that
late hypocalcemic tetany is more common in Hispanic
infants, although this is not well demonstrated due to the
limited published data [14]. Regardless, serum calcium in
the cord blood and in the first days of life is likely con-
trolled by a variety of factors, of which vitamin D is only
one factor.
Limited previous research is generally consistent with
our findings. Park et al [15] studied Korean infants at 2 to
5 months of age and found no relationship between 25
(OH)D level and BMC assessed by DXA even though
many of the infants had very low 25(OH)D levels. They
speculated that this is due primarily to passive absorption
of calcium at this age. It has been suggested but is not pro-
ven that early life calcium absorption is primarily non-vita-
min D dependent [2]. However, it is likely that by three
months of age, vitamin D has a key role in calcium absorp-
tion, especially in breast-fed infants with a relatively low
calcium intake compared to formula-fed infants. Whether
the greater bioavailability of calcium from human milk
compared to formula affects the needed level of 25(OH)D
by infants is unknown.
Greer et al [16] found an increase in 25(OH)D from 24
to 39 ng/mL at three months of age with the provision of
400 IU/day of vitamin D to breast-fed infants. These
results are similar to ours, with slightly higher 25(OH)D
values found in the Greer study. Direct comparisons
however of 25(OH)D values between studies conducted
in the past and recent studies should be done with cau-
tion due to well-documented variations in assay
techniques.
Therefore, in considering early vitamin D supplementa-
tion, the question becomes whether there is physiological
benefit to rapid replenishment with vitamin D (e.g. high
doses of vitamin D in early life) with or without monitor-
ing of 25(OH)D levels or whether the 400 IU/day dose is
adequate. Our data, from this small dataset, can only be
used to partially answer this question specifically related
to bone health. However, it appears that, at least in a
southern US setting, 400 IU/day is adequate for infants
regardless of vitamin D status at birth. We cannot rule out
the possibility that a small number of infants will be hypo-
calcemic in the first weeks of life with this approach, but,
this appears to be uncommon and may be more related to
PTH function than vitamin D. Further research is needed
relative to the etiology of symptomatic hypocalcemia in
the first weeks of life.
Studies in adults have found a greater increase in 25
(OH)D levels in subjects who started at a lower level
before supplementation [17]. Similar data are not readily
available in pediatric populations. Caution should be used
in interpreting any results for changes in 25(OH)D based
on baseline levels. It has been suggested that these results
may reflect a regression to the mean phenomenon or may
be related in part to measurement variability (8). However,
the findings in our study appear meaningful in that the
provision of vitamin D at a dose of 400 IU/day led to
mean values that were above 30 ng/mL regardless of start-
ing value or ethnicity. The 30 ng/mL target is well above
that likely to be needed for adequate vitamin D status in
the newborn based upon the recent recommendations of
the Institute of Medicine [2].
The effects of maternal vitamin D deficiency are com-
plex and may extend beyond bone health effects in infants.
Provision of all pregnant and lactating women with the
Recommended Daily Allowance of 600 IU/day is an
important public health strategy. Nonetheless, such sup-
plements are not universally consumed by the population.
T h eH i s p a n i cc o m m u n i t ym a yb ea th i g h e rr i s kd u et o
darker skin pigmentation, greater obesity, lower dairy
intake and less supplement use. It has been suggested that
all Hispanics and all pregnant and lactating women have
their 25(OH)D levels monitored [4].
Of note is that 25(OH)D levels in a southern United
States climate are low despite sunshine exposure year
round at the latitude in Houston. Furthermore, there is a
seasonal dependence of 25(OH)D levels although we did
not have enough subjects to identify the degree to which
this seasonal dependence was affected by ethnicity. We
had previously shown a seasonal dependence of 25(OH)
D levels in prepubertal girls in Houston [18] with no dif-
ferences in calcium absorption or kinetics between
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that a southern US location is not protective against sea-
sonal deficiency of vitamin D or low cord 25(OH)D
levels.
Conclusion
We found that low 25(OH)D levels are common in
newborns in a southern US climate, especially among
Hispanic infants. Improvement occurred with vitamin D
supplementation and was not related to changes in bone
mineral content. Our findings support current guidelines
to begin vitamin D supplementation of 400 IU/day to all
breast-fed infants in the first week of life and to further
encourage the provision of adequate vitamin D to preg-
nant women. Larger studies are needed in diverse popu-
lations at various latitudes to further characterize the
relationship between vitamin D supplementation and
bone mineral content.
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